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Abstract
Purpose: Folate metabolism, with its importance to DNA repair, provides a promising region for genetic investigation of
lung cancer risk. This project investigates genes (MTHFR, MTR, MTRR, CBS, SHMT1, TYMS), folate metabolism related nutrients
(B vitamins, methionine, choline, and betaine) and their gene-nutrient interactions.
Methods: We analyzed 115 tag single nucleotide polymorphisms (SNPs) and 15 nutrients from 1239 and 1692 non-Hispanic
white, histologically-confirmed lung cancer cases and controls, respectively, using stochastic search variable selection (a
Bayesian model averaging approach). Analyses were stratified by current, former, and never smoking status.
Results: Rs6893114 in MTRR (odds ratio [OR] = 2.10; 95% credible interval [CI]: 1.20–3.48) and alcohol (drinkers vs. non-
drinkers, OR= 0.48; 95% CI: 0.26–0.84) were associated with lung cancer risk in current smokers. Rs13170530 in MTRR
(OR = 1.70; 95% CI: 1.10–2.87) and two SNP*nutrient interactions [betaine*rs2658161 (OR= 0.42; 95% CI: 0.19–0.88) and
betaine*rs16948305 (OR= 0.54; 95% CI: 0.30–0.91)] were associated with lung cancer risk in former smokers. SNPs in MTRR
(rs13162612; OR = 0.25; 95% CI: 0.11–0.58; rs10512948; OR = 0.61; 95% CI: 0.41–0.90; rs2924471; OR = 3.31; 95% CI: 1.66–6.59),
and MTHFR (rs9651118; OR= 0.63; 95% CI: 0.43–0.95) and three SNP*nutrient interactions (choline*rs10475407; OR = 1.62;
95% CI: 1.11–2.42; choline*rs11134290; OR = 0.51; 95% CI: 0.27–0.92; and riboflavin*rs8767412; OR = 0.40; 95% CI: 0.15–0.95)
were associated with lung cancer risk in never smokers.
Conclusions: This study identified possible nutrient and genetic factors related to folate metabolism associated with lung
cancer risk, which could potentially lead to nutritional interventions tailored by smoking status to reduce lung cancer risk.
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Introduction
Lung cancer accounted for 15% of all cancer diagnoses in 2010
and 28% of all cancer deaths [1]. Furthermore, the overall 5-year
survival rate remains at 15% for all stages of lung cancer combined
[1]. While smoking cigarettes is the dominant risk factor for lung
cancer, only a fraction of smokers ever develop the disease [2],
suggesting that lung cancer development depends on other factors,
most likely genetic and other environmental factors (e.g., diet)
[2,3,4]. Research suggests that dietary folate status [5,6] and
variation within genes that comprise the folate metabolic pathway
[7,8,9,10,11] may be associated with lung cancer risk.
Folate has been shown to be an important nutrient for DNA
synthesis, repair, and methylation [8] and therefore, may influence
cancer risk. Studies have shown that low folate intake is associated
with increased DNA strand breaks, decreased DNA methylation,
and reduced DNA repair capacity [12]. High dietary folate intake
(defined as above the median control intake level) is associated
with a 40% reduction in lung cancer risk among former smokers,
after adjusting for age, sex, ethnicity, total energy intake, body
mass index, family history of smoking, pack years smoked, and
alcohol consumption [13]. The protective effect of increased folate
intake also appears to hold among current smokers [14]. More
recently, high blood serum levels of vitamin B6 and methionine
have been found to offer different levels of protection against lung
cancer for never, former and current smokers [6].
Aside from dietary folate, genes in the folate metabolic pathway
have also been associated with lung cancer risk. Folate genes
implicated in lung cancer risk include methylenetetrahydrofolate
reductase (MTHFR) [7]; thymidylate synthase (TYMS) [10,15];
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serine hydroxymethyltransferase 1 (SHMT1) [11]; and cystathio-
nine b-synthase (CBS) [8]. Other suspected genes include
methionine synthase (MTR) and methionine synthase reductase
(MTRR); however, results for these genes have been equivocal [7].
This study investigates the roles of folate status, nutrition, genes
and gene-nutrient interactions in the folate metabolic pathway in
lung cancer risk. Previous assessments of the association between
folate status and lung cancer have focused on nutrition, without
consideration of genetic polymorphisms, and studies that have
assessed genes in the folate metabolic pathway included only small
panels of single nucleotide polymorphisms (SNPs). The current
study examines multiple SNPs in important folate genes, while also
investigating dietary intake of B vitamins, folate, methionine,
betaine, and choline, allowing for the joint assessment of the effects
of diet and genetic status and pairwise gene-nutrient interactions
on lung cancer risk.
This study uses a more powerful approach than standard
methods for detecting genes and nutrients associated with lung
cancer, known as stochastic search variable selection (SSVS)
[16,17]. SSVS, a form of Bayesian model averaging, randomly
searches through all possible models, guided by the data, to
identify the most likely risk factors accounting for the uncertainty
of variable selection [17]. We employed stochastic search here for
multiple reasons. First, such stochastic search methods have been
effective in analyzing SNP data, particularly in genetic association
studies (e.g. [17,18,19,20,21]). Second, simulation studies using the
case-control design have demonstrated that SSVS has a greater
accuracy to recover the ‘‘true model’’ than standard variable
selection methods, such as forward, backward or stepwise selection
[17]. Third, other researchers have shown that SSVS outperforms
penalized sparse regression [22] and standard lasso techniques
[23], especially in problems investigating many SNPs where then




This study was approved by both the MD Anderson and The
University of Texas Health Science Center at Houston Institu-
tional Review Boards (IRB). The University of Texas Health
Science Center at Houston IRB is also the governing IRB for the
UT School of Public Health, as a member school of the University
of Texas Health Science Center at Houston. This study involved
secondary analysis of de-identified data. The original data
collection was consented by written informed consent that
discussed such analyses.
Study Population
The study population consisted of histologically confirmed lung
cancer cases (n = 1239) and controls (n = 1692) diagnosed between
1995 and 2007 from an ongoing lung cancer case-control study
conducted at The University of Texas MD Anderson Cancer
Center. Details of the recruitment for the parent study have been
published elsewhere [26,27]. Briefly, newly diagnosed cases of lung
cancer were recruited from patients at MD Anderson Cancer
Center. Controls (individuals without a previous diagnosis of
cancer, except non-melanoma skin cancer) were recruited from
Kelsey-Seybold clinics, the largest private physician group in
Houston, Texas. The overall recruitment rate was about 75%.
Dietary and Demographic Data
Dietary information, demographic factors, and smoking history
were obtained through a personal interview. Trained interviewers
administered a food frequency questionnaire (FFQ) that is a
modified version of the National Cancer Institute’s Health Habits
and History Questionnaire [28]. The FFQ solicited usual intake
for the year prior to the interview and included an open-ended
food section and behavior-related dietary questions regarding
restaurant dining and food preparation. The validity of the Block
FFQ has been described across various populations [29,30,31].
The questionnaire was modified for the parent study to include
ethnic foods commonly consumed in the greater metropolitan area
of Houston, Texas. The estimated intake of several nutrients and
beverages in controls was comparable to that reported by adults
who participated in the National Health and Nutrition Examina-
tion Survey (NHANES), 1999–2000 [32,33,34].
In the current study, we limit our analysis to non-Hispanic
whites to ensure a large enough sample size to stratify by smoking
status and minimize confounding due to population stratification.
We also focus on this population to keep our inference consistent
with that of the earlier studied Spitz model for non-genetic risk of
lung cancer [35].
Questions with multiple foods on the FFQ were weighted for
each individual food item by the consumption of that food in the
NHANES population (as in [36]). Then, the nutrient content of
each food was derived from the U.S. Department of Agriculture
National Nutrient Database for Standard Reference, Release 21
(USDA SR21) [37]. Thus, weighted averages of the individual
foods in multiple food items as well as the items with one food were
linked to the USDA SR21 to calculate nutrient intakes. We
determined the daily nutrient intake of the following macro- and
micronutrients: energy, carbohydrate, fat, protein, betaine, cho-
line, methionine, folate, pantothenic acid (vitamin B5), niacin
(vitamin B3), riboflavin (vitamin B2), thiamin (vitamin B1), vitamin
B6, and vitamin B12. All nutrient values were adjusted for total
energy intake per the method of Willett and Stampher [38].
In our analysis, alcohol consumption reported on the FFQ was
first dichotomized into non-drinkers (reported 0 drinks on the
FFQ) versus drinkers (reported any drinking). After significance
was assessed, we later categorized alcohol into: nondrinker, 0.1–
4.9 g/day, 5.0–14.9 g/day, 15–29.9 g/day, and greater than
30 g/day as in [39] for comparative discussion purposes. We
categorized smoking status as never (smoked fewer than 100
cigarettes in their lifetime), former (smoked at least 100 cigarettes
in their lifetime and quit more than 1 year prior to study
enrollment), or current (currently smoking or quit less than 1 year
prior to enrollment) smokers [35]. Family history of smoking-
related cancer in a first-degree relative was included in the analysis
on the basis of a yes/no response. For all smokers, we computed
pack years. For former smokers, we additionally computed years
since cessation. For never and former smokers, we recorded
exposure to environmental tobacco smoke, defined as exposure to
someone else’s cigarette smoke at work or at home on a regular
basis, as described in [35].
SNP Selection and Genotyping
We selected 293 SNPs across the genes in the folate metabolism
pathway. The full panel of SNPs genotyped, their function and
location are given in Table S1. These SNPs consist of all those
listed in the HapMap and National Institute of Environmental
Health Sciences (NIEHS) SNP databases as members of the
above- mentioned genes of the folate metabolism pathway. We
consider a SNP to belong to a gene if it is located within 500 kilo
base pairs (kb) of the gene. No other genes with known function in
folate metabolism have been implicated in lung cancer risk, so we
focus our analyses on this set. Thus, our custom chip was
composed of SNPs from these genes in the folate pathway. The
Folate Genes Nutrients and Lung Cancer Risk
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selected SNPs were genotyped using the custom iSelect Infinium
Beadchip design in conjunction with SNPs for other projects.
Participants’ genomic DNA was extracted from peripheral
blood lymphocytes and stored at 280uC until use. We genotyped
SNPs from case and control DNA samples using Illumina’s
BeadXpress platform according to the standard 3 day protocol.
Genotypes were autocalled using the BeadStudio software. SNPs
with genotype call rates of less than 95% or SNPs with a minor
allele frequency less than 0.01, or more than 10% missing across
our data set were omitted from our analysis (39 SNPs removed). A
chi-square test confirmed that the pattern of missing observations
for each SNP was independent of the affection status of the
subjects. For the multivariable analysis, individuals missing SNPs
were removed, and 2,225 subjects (1175 cases, 1050 controls)
remained in the analysis.
Once the data set was reduced to genotypes not missing SNPs,
we reduced the dimensionality and collinearity by empirically
selecting tag SNPs using the method of Carlson et al. [40], with a
threshold of r2 = 0.8. We selected representative tag SNPs that
were in exons, or previously mentioned in prior studies, when
available. We examined Hardy-Weinberg proportions for the tag
SNPs using PLINK [41], and all tag SNPs were found to be in
Hardy-Weinberg equilibrium at the 0.001 level.
Statistical Analysis
Continuous demographic variables were compared using two-
sample t-tests; nutrient variables were compared using Wilcoxon
rank-sum tests; and categorical demographic variables were
compared with Pearson’s chi-squared test. For model selection,
we used a Bayesian model averaging method known as stochastic
search variable selection (SSVS) [16] applied to logistic regression
[17,20]. SSVS uses Markov Chain Monte Carlo (MCMC)
methods to search through all possible models to identify joint
genetic and dietary effects on lung cancer risk. These methods
have been shown to be more powerful than traditional stepwise
selection methods [17,20]. SSVS has two levels of prior
distributions: the prior on the model coefficient or odds ratio,
which includes a correlation matrix for genetic factors defined by
linkage disequilibrium (LD), and the prior for probability of
selection for each variable [17,20].
Prior Distribution. To conform with fully Bayesian meth-
ods, we modeled the prior correlation among the tag SNPs to be
analyzed using the pairwise r2 values from the NIEHS Environ-
mental Genome Project [42], external to our data. SNPs more
than 400,000 base pairs apart or from different chromosomes were
assumed to be independent. As a reliable estimate for the
correlation of nutrient values could not be externally defined,
the priors for the dietary coefficients were independent normal
distributions centered at 0 [17]. We assumed gene-environment
independence and modeled the priors for the coefficients for the
genes and nutritional covariates as uncorrelated. We also used a
prior probability of inclusion of 0.5 for each variable, which has
been shown to best control for both false-positive and false-
negative results when the prior information for all risk factors may
not be available [17].
Smoking Variables and Additional Covariates. Because
smoking is a well-established risk factor for lung cancer, cases and
controls were frequency matched by smoking status in the original
study design. Thus, we stratified subjects into three groups based
on smoking history: never smokers, former smokers, and current
smokers as in Spitz et al. [35]. Other non-genetic risk factors for
lung cancer that have been established as significant were included
in each model following the approach in Spitz et al. [35], and were
not subject to variable selection. For never smokers, we included
sex, age, family history of cancer, and exposure to environmental
tobacco smoke. For former smokers, we included sex, age, family
history of cancer, and a factor indicating whether the subject
stopped smoking before age 40, between ages 40 and 53, or at age
54 or later, selected for its stronger association with lung cancer
risk than pack years smoked (as described in [35]). For current
smokers, we included sex, age, family history of cancer, and a
factor indicating whether pack years smoked were less than 27,
between 27 and 53, between 54 and 82, or 83 or greater, as in
[35]. Genotypes were coded additively, using homozygous for the
major allele as the reference genotype.
Markov Chain Monte Carlo Analysis. All MCMC com-
putations were completed using WinBugs [43], R and the
R2WinBUGS package [44] to prepare the data (categorization,
clean missing, stratification) and to compute posterior inference.
We ran two chains with distinct starting values for 300,000
iterations and used the last two thirds of the iterations to estimate
our posterior quantities to ensure convergence to the stationary
distribution, as described in [45]. The two chains for each stratum
were found to have very high correlations, indicating that they
converged to the same model, and were pooled for inference.
The statistical analysis proceeded in three stages (see Figure 1):
In stage 1, we identified the tag SNPs and nutrients to be analyzed.
Stage 2 consisted of a stochastic search of the SNPs and a separate
stochastic search of the nutrients to screen for promising SNPs and
nutrients. Any SNPs and nutrients with a posterior probability of
inclusion greater than 0.35 proceeded to stage 3 [17,46]. In stage
3, we jointly searched through SNPs and nutrients and their
corresponding SNP and nutrient interactions for those SNPs and
nutrients that proceeded to stage 3. The gene-nutrient interactions
consisted of the pairwise product of each SNP additively coded
and the nutrient as a continuous variable. For the stage 3 model,
we selected genes, nutrients and interactions with a marginal
Bayes factor greater than 3 which indicates moderate evidence for
association [47] (marginal Bayes factors were computed similar to
the SNP specific Bayes factor in [48], based on the marginal
probabilities of inclusion). In addition to computing the Bayes
factor, we also computed the expected false discovery rate, as
defined in [49]. The Bayes factor of 3 or greater also coincides
with controlling the false discovery rate to less than 0.15. We
estimated the odds ratios (ORs) using the posterior model
averaged coefficients, conditional on inclusion and their 95%
credible intervals (95% CI), as in [20].
Sample Size for SNP Analysis. There were 763 current
smokers with complete genotype and covariate data: 406 cases and
357 controls. There were 719 former smokers: 453 cases and 266
controls, and 743 never smokers: 316 cases and 427 controls.
Sample Size for Nutritional Analysis. There were 545
current smokers with full nutritional and covariate data available:
250 cases and 295 controls. There were 547 former smokers: 319
cases and 228 controls, and there were 685 never smokers: 279
cases and 406 controls.
Determining the final model. The following sample sizes
reflect the numbers of subjects with available genotype and
nutritional data. Of the current smokers, there were 577 subjects,
with 263 cases and 314 controls, in whom we investigated 12 SNPs
and 2 nutritional variables and 24 interaction terms. Of the former
smokers, there were 572 subjects, with 337 cases and 235 controls,
in whom we investigated 14 SNPs and 7 nutritional variables and
96 interactions. For never smokers, the sample size was 743, with
304 cases and 439 controls, and we investigated 26 SNPs and 6
nutritional variables and 150 interactions. Highly collinear
interactions were dropped from the selection process (2 interac-
Folate Genes Nutrients and Lung Cancer Risk
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e53475
tions for former smokers, and 6 interaction terms for never
smokers).
Results
We summarize selected demographic variables and nutritional
variables in our study population in Table 1. There were equal
proportions of male and female cases (50.5% versus 49.5%,
respectively) but slightly fewer male (46.7%) than female controls
(53.3%). The mean age of cases was significantly higher than the
mean age of controls (63.5 years versus 57.2 years, p,0.001). Our
sample had a higher proportion of former and current smokers in
the cases (72.4%) than in the controls (58.8%). Cases who smoked
had significantly more pack years than controls (mean 78.3 pack
years versus mean 59.0 pack years, p,0.001). (Our analyses were
stratified by smoking status and adjusted for pack years.) More
controls (41.1%) were never smokers than cases (27.5%). Current
and former smokers reported exposure to environmental tobacco
smoke in close to equal proportions of cases and controls (68.2%
versus 68.5%, respectively), and significantly more cases than
controls reported having at least one relative with a smoking-
related cancer (30.3% versus 21.2%, respectively).
Only a few dietary factors differed significantly across cases and
controls. Considering the median grams of alcohol drunk, cases
reported significantly less drinking (median= 0.27 g) than controls
(median= 0.82 g). Cases reported eating significantly less protein
(median= 73.58 g) than controls (76.43 g). Cases also reported
significantly less betaine (median= 48.94 mg), methionine (med-
ian= 1480.22 mg), niacin (median = 21.99 mg), vitamin B6 (med-
ian= 5.43 mg), and vitamin B12 (median = 5.26 mcg) than con-
trols (medians = 53.20 mg, 1554.95 mg, 22.67 mg, 2.07 mg,
5.42 mcg, respectively).
Initial Screen for Genotypes
Our initial screen for SNPs associated with lung cancer stratified
by smoking status is reported in Table S2. Those SNPs with a PPI
greater than 35% were further analyzed in the final model that
jointly considered genes and nutrition. Among current smokers,
we identified 12 SNPs for further consideration: 2 SNPs from the
CBS gene, 7 SNPs from MTRR, 2 SNPs from SHMT1, and 1 SNP
from TYMS. In former smokers, we identified 14 SNPs: 3 SNPs
Figure 1. Analysis Flow Chart. This figure depicts the flow of analysis. We analyzed SNPs and nutrients in parallel, using stochastic search
methodology in stage 2. Then the most important SNPs and nutrients were jointly investigated along with the gene-nutrient interactions in stage 3,
again using stochastic search methodology.
doi:10.1371/journal.pone.0053475.g001
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from the CBS gene, 2 from MTHFR, 1 from MTR, 7 from MTRR,
and 1 from TYMS. In never smokers, we identified 26 SNPs: 4 in
CBS, 8 in MTHFR, 11 in MTRR, 1 in SHMT1, and 2 in TYMS.
Initial Screen for Nutrients
The results from our initial screen for potential nutrients
associated with lung cancer are reported in Table S3, stratified by
smoking status. Those nutrients with a PPI greater than 35% were
further analyzed in our final model that jointly considered genes
and nutrition. In current smokers, only alcohol and vitamin B6
were identified for consideration in the final model. In former
smokers, we identified alcohol, carbohydrates, protein, betaine,
methionine, thiamin, and vitamin B12 for further consideration. In
never smokers, the nutrients for further consideration were
carbohydrates, protein, choline, folate, riboflavin, and thiamin.
Final Models
The collinearity of variables in our final model was controlled
using the tag SNP selection process described above. We include
the LD matrix describing the LD between the final selected SNPs
in Table S4 (max r2,0.63) and the correlations between the final
selected nutrients in Table S5 (max r2,0.62). Simulation studies
have shown stochastic search to perform well in the presence of
moderate collinearity of magnitude on the order of 0.6 [20].
Current Smokers. In current smokers, MTRR (rs6893114)
and alcohol were associated with lung cancer risk, after adjusting
for sex, age, pack years, and family history (Table 2). MTRR had
the highest PPI, and the minor allele of rs6893114 conferred a
twofold increase in lung cancer risk (OR=2.10; 95% CI: 1.20–
3.48). As alcohol drinking appeared to be protective among
current smokers (OR=0.48; 95% CI: 0.26–0.84), we further
examined alcohol intake using more detailed categorization [39]:
nondrinker, 0.1–4.9 g/day, 5.0–14.9 g/day, 15–29.9 g/day, and
greater than 30 g/day. We computed an adjusted odds ratio for
each level (see Table 3), using non-drinkers as the reference
category and adjusting for age, sex, family history, pack years, and
the MTRR variant. The two lowest drinking categories (light and
moderate drinking) showed a decrease in risk from drinking: 0.1–
4.9 g/day is associated with a 39% decrease in risk, (OR=0.61;
95% CI: 0.40–0.93) and 5–14.9 g/day is associated with a 42%
decrease in risk (OR=0.58; 95% CI: 0.34–0.99). We did not find
Table 1. Distribution of Epidemiologic/Demographic Variables and Nutrition Variables.
Variablea Category Cases (N=1692) Controls (N=1239) P-valueb
Gender, n (%) Male 854 (50.5) 579 (46.7)
Female 838 (49.5) 660 (53.3) 0.049
Age, mean (SD) 63.5 (11.0) 57.2 (13.2) ,0.001
Smoking status, n (%) Never 466 (27.5) 510 (41.1)
Former 645 (38.1) 326 (26.3)
Current 581 (34.3) 403 (32.5) ,0.001
Pack yearsc, mean (SD) 78.3 (73.7) 59.0 (49.8) ,0.001
ETSd, n (%) Exposed 236 (68.2) 322 (68.5)
Unexposed 110 (31.8) 148 (31.5) 0.97
Family history, n (%) None 936 (69.7) 938 (78.8)
$1 relative 406 (30.3) 253 (21.2) ,0.001
Nutrition, median Total calories (kcal) 1734.91 1717.92 0.752
Alcohol (g) 0.27 0.82 0.002
Macronutrientse Carbohydrate (g) 233.95 231.80 0.256
Protein (g) 73.58 76.43 ,0.001
Total Fat (g) 67.82 67.98 0.876
Micronutrientse Betaine (mg) 48.94 53.20 0.003
Choline (mg) 141.15 143.04 0.316
Folate (mg) 501.19 514.48 0.344
Methionine (mg) 1489.22 1554.95 ,0.001
Niacin (mg) 21.99 22.67 0.005
Pantothenic acid (mg) 5.43 5.33 0.116
Riboflavin (mg) 2.23 2.23 0.661
Thiamin (mg) 1.47 1.47 0.801
Vitamin B6 (mg) 2.00 2.07 0.012
Vitamin B12 (mg) 5.26 5.42 0.005
aTotals may not equal total N due to missing data.
bP-value from the two-sided chi-squared test (for categorical variables), Student’s t-test (for continuous demographic variables), or Wilcoxon rank sum test (for nutrition
variables).
cPack years computed for former and current smokers only.
dETS = Environmental Tobacco Smoke exposure in never smokers.
eMacro- and micronutrients are adjusted by total calorie intake.
doi:10.1371/journal.pone.0053475.t001
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any evidence of gene-nutrient interactions for current smokers in
our data.
Former Smokers. For former smokers, one SNP in MTRR
(rs13170530) showed evidence of an association with lung cancer
risk after adjusting for age, sex, age at smoking cessation, and
family history. We also found a significant interaction between
betaine and a variant in MTRR (rs2658161) and a variant in
TYMS (rs16948305). The minor allele in MTRR (rs13170530)
confers a 70% increase in risk (OR=1.70; 95% CI: 1.10–2.87).
Although no nutrient main effects were significant, betaine was a
part of two meaningful interactions that were both protective
among former smokers: betaine*rs2658161 (OR=0.42; 95% CI:
0.19–0.88) and betaine*rs169484305 (OR=0.54, 95% CI: 0.30–
0.91). Thus each copy of the minor allele of rs2658161 improves
the protective effect of ingesting more betaine. Zero copies of the
minor allele results in no reduction in risk, 1 allele results in a 58%
reduction in risk per mg increase in betaine intake, while 2 copies
of the minor allele result in 0.83% reduction in risk. Individuals
heterozygous for the minor allele of rs169484305 receive a 46%
decrease in lung cancer risk per mg betaine consumed, while those
homozygous for the minor allele have a 70% decrease in risk.
Never Smokers. For never smokers, 4 SNPs, three in MTRR
(rs13162612, rs10512948, rs2924471) and one in MTHFR
(rs9651118), were associated with lung cancer risk, after adjusting
for environmental tobacco exposure, sex, age, and family history.
The minor allele for rs13162612 was associated with a 75%
reduction in lung cancer risk (OR=0.25; 95% CI: 0.11–0.58), and
rs10512948 was associated with a 39% decrease in lung cancer risk
(OR=0.61; 95% CI: 0.41–0.90). The third SNP from MTRR,
rs2924471, was associated with a 3-fold increased risk (OR=3.31;
95% CI: 1.66–6.59). In addition to the genetic main effects, three
nutrient by gene interactions were selected: choline*rs10475407,
choline*rs11134290 and riboflavin*rs876712. The choli-
ne*rs10475407 interaction conferred risk (OR=1.62; 95% CI:
1.11–2.41). Being heterozygous for the minor allele of rs10475407
is associated with a 62% increased risk, while being homozygous
for the minor allele is associated with a 2.6 fold increase in risk for
each mg increase of choline intake. On the other hand, individuals
heterozygous for the minor allele of rs11134290 had a 49%
decrease in risk (OR=0.51; 95% CI: 0.27–0.92) for increased
choline intake, while those homozygous for the minor allele had a
74% decreased risk per mg increased intake in choline. Individuals
heterozygous for the minor allele of rs876712 have a 60%
decreased risk per increased intake in riboflavin, which increases to
Table 2. Final Model Stratified by Smoking Status.
Model Variable Genea ORb 95% CI PPI Bayes factor
Current Smokers alcohol 0.48 0.26–0.84 0.90 8.81c
rs6893114 MTRR 2.10 1.20–3.48 0.88 7.25c
Former Smokers betaine*rs2658161 MTRR 0.42 0.19–0.88 0.82 4.62c
rs13170530 MTRR 1.70 1.10–2.87 0.81 4.21c
betaine*rs16948305 TYMS 0.54 0.30–0.91 0.76 3.10c
rs2658161 MTRR 2.23 0.96–4.98 0.72 2.22
betaine 0.71 0.34–1.35 0.32 0.47
rs16948305 TYMS 0.89 0.54–1.62 0.23 0.30
Never Smokers rs2924471 MTRR 3.31 1.66–6.59 0.99 78.31c
rs13162612 MTRR 0.25 0.11–0.58 0.98 65.63c
rs10512948 MTRR 0.61 0.41–0.90 0.83 5.17c
choline*rs10475407 MTRR 1.62 1.11–2.42 0.82 4.83c
riboflavin*rs876712 MTRR 0.40 0.15–0.95 0.80 3.98c
choline*rs11134290 MTRR 0.51 0.27–0.92 0.78 3.48c
rs9651118 MTHFR 0.63 0.43–0.95 0.75 3.05c
rs11134920 MTRR 0.68 0.44–1.05 0.48 0.92
riboflavin 1.57 0.65–4.03 0.45 0.81
rs10475407 MTRR 0.77 0.57–1.04 0.38 0.62
choline 0.75 0.35–1.78 0.36 0.55
rs876712 MTRR 0.73 0.41–1.29 0.35 0.55
aSNPs located within 500 kb of given gene.
bOdds ratios for current smokers adjusted for sex, age, family history of smoking-related cancers, and pack years smoked; odds ratios for former smokers adjusted for
sex, age, family history, and age at smoking cessation; odds ratios for never smokers adjusted for sex, age, family history, and exposure to secondhand tobacco smoke.
cBayes factor greater than or equal to 3; included in the final model.
doi:10.1371/journal.pone.0053475.t002
Table 3. Further Examination of Alcohol from the Final Model
for Current Smokers (263 Cases/314 Controls).
Alcohol Intake Category Cases Controls ORa 95% CI
Non-drinkers 116 86 1 Reference
0.1–4.9 g/day 72 111 0.61 0.40–0.93
5–14.9 g/day 31 58 0.58 0.34–0.99
15–29.9 g/day 21 30 0.73 0.38–1.37
.30 g/day 23 29 0.75 0.40–1.40
aOdds ratios adjusted for age, sex, family history, pack years, and MTRR mutants.
doi:10.1371/journal.pone.0053475.t003
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84% for those homozygous for the minor allele (ribofla-
vin*rs876712 OR=0.40; 95% CI: 0.15–0.95).
Discussion
This study identified various nutritional factors and genetic
factors related to folate metabolism that jointly play a role in lung
cancer risk. Performing analyses stratified by smoking status
(current, former, and never), we found folate-related dietary and
genetic factors, and gene*nutrient interactions were associated
with lung cancer risk in current, former, and never smokers.
Alcohol was associated with lung cancer risk in current smokers,
while gene-nutrient interactions were associated with varying risk
in former and never smokers. SNPs inMTRR were associated with
lung cancer risk in current, former and never smokers, while a
variant in MTHFR was associated with lung cancer risk in never
smokers. An additional SNP in TYMS was found to interact with
betaine to influence lung cancer risk in former smokers.
Recent research has shown mixed results regarding the
association between alcohol drinking and lung cancer risk in
non-Hispanic whites [39,50,51,52]. Evidence is more consistent in
never smokers for no association between alcohol and lung cancer
risk [50], which aligns with the findings of the current study. For
current smokers, there is less evidence regarding the association
between alcohol intake and lung cancer risk [51]. Recent studies
suggest that the influence of alcohol may depend on the type of
alcohol consumed, citing a possible protective effect for wine and
increased risk for beer [52]. Other studies show a marginal, non-
linear relationship between alcohol intake and lung cancer risk,
with moderate drinking having a protective effect [39]. The strong
posterior probability for alcohol seen here suggests that alcohol
may be associated with lung cancer risk in current smokers;
however, this study does not provide any definitive resolution
regarding the mediating effects of smoking on the relationship
between alcohol and lung cancer risk. Possible explanations for
this apparent association are that cases stopped drinking recently
relative to their diagnosis or simply under-report their drinking
because of recent diagnosis.
Our analysis also identified several polymorphisms associated
with lung cancer risk. For all smoking statuses, different SNPs in
MTRR exhibited strong evidence for association with lung cancer
risk. In current smokers, we identified rs6893114 with increased
risk, for former smokers, we identified rs13170530 with increased
risk, and for never smokers we identified multiple MTRR SNPs:
rs13162612 and rs10512948 were associated with decreased risk;
and rs2924471 was associated with increased risk for lung cancer.
There is very little information regarding the association ofMTRR
with lung cancer, with most studies focusing on MTRR A66G
(rs1801394) [7,9,53]. Two previous studies found no association
for MTRR A66G [7,53], while a third found increased risk [9]. All
three studies mentioned an interaction between smoking status
and A66G alleles. The fact that the current study also found
polymorphisms in MTRR provides further evidence of an
association between MTRR and lung cancer.
In never smokers, an additional polymorphism in MTHFR,
rs9651118, is associated with decreased lung cancer risk. Over the
past decade, many researchers have focused their efforts on two
particular polymorphisms of MTHFR, C677T and A1289C, owing
to variants from wild-type at these loci resulting in altered serum
folate levels [7,54,55]. However, results concerning these two loci
and their association with lung cancer risk are often inconclusive
[54,56]. In the current study, C677T was not selected as being
associated with lung cancer. The SNP associated with lung cancer
in never smokers, rs9651118 (T/C), has a borderline Bayes factor
(3.05), and moderate protective effect for lung cancer (37%
decrease in risk). This SNP is in low LD with the C677T and
A1298C polymorphisms forMTHFR (r2,0.20) and is located in an
intronic region of MTHFR. (We do not use D9 here, because by
D9, all tag SNPs have D9.0.9 with C677T.) Given the findings in
this study, further investigation of this SNP is encouraged.
Located at 1p36.3, the MTHFR gene codes for the methyenete-
trahydrofolate reductase that converts 5,10-methylenetetrahydro-
folate to 5-methylenetetrahydrofolate, which is the primary
circulating form of folate and provides methyl groups for synthesis
of methionine, an important factor for healthy DNA methylation.
MTRR codes for methionine synthase reductase, which controls
methionine synthase, which uses methionine as a methyl donor for
DNA methylation. A disruption in any of these three metabolites
can lead to chromosome instability and DNA under-methylation,
and ultimately to cancer [57,58]. TYMS codes for thymidylate
synthase, an enzyme that is key to a reaction providing thymidine,
an important nucleotide used in DNA synthesis and repair.
Increased activity is expected to be associated with healthier DNA,
while decreased activity is expected to be associated with more
DNA damage and thus higher cancer risk [10,53].
Our analysis did not detect any nutrient main effects; however,
for each smoking status we did detect statistical interactions. In
former smokers, we detected a statistical interaction between
variants in MTRR and TYMS and betaine, and in never smokers
we detected interactions between variants in MTRR and choline
and riboflavin. The Bayes factors indicated no evidence for any
associations between lung cancer and the main effects of betaine,
choline or riboflavin or the SNPs involved in the interactions, but
as the intake of betaine and allele dose of rs2658161 (MTRR) and
rs16948305 (TYMS) increased, our model indicated a reduction in
lung cancer risk for former smokers. With never smokers, a
statistical interaction with choline and rs10475407 (MTRR) lead to
an increased risk, while the interactions of choline with
rs11134290 (MTRR) and riboflavin with rs876712 (MTRR) were
modeled to decrease lung cancer risk. Researchers are just
beginning to investigate choline and betaine intake in human
studies, due to the recently available database linkage to FFQs for
betaine and choline [59]. Some human studies have linked breast
cancer [60] and colon cancer [61] to choline and betaine intake
levels, while other studies have found no association [62,63,64].
Riboflavin has been reported with mixed associations with lung
cancer as well [6,65,66]. Therefore, the literature offers other
studies that support many of the SNPs found by this Bayesian
model averaging method. However, this is one of the first studies
to jointly model these risk factors for lung cancer, and further
validation of these findings is needed.
The findings of the current study need to be interpreted in the
light of certain limitations especially for the nutrition data. First,
because this study sample was restricted to non-Hispanic whites,
our findings may not generalize to other ethnicities. Second, this
study is a cross-sectional study and information on all variables was
collected upon recruitment, and we cannot investigate any real
change in behavior over time, such as a change in drinking
behavior. Third, the controls were selected from an HMO in the
greater Houston metropolitan area. Therefore, controls may not
be fully representative of the general population. The fact that
these individuals sought medical care might suggest a higher
awareness of health and, perhaps, of the importance of proper
nutrition. Therefore, the nutrition profiles may not accurately
reflect intake in the general population. However, a previous study
found the intake of various food items in this population to be
comparable to those found by NHANES [32,33,34].
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Additionally, the pattern of missing data is significantly different
in smokers versus non-smokers, but since we stratify by smoking
status, the bias will be minimal. The missing pattern between cases
and controls are not significantly different. The nutrition data were
collected using food frequency questionnaires, which have the
well-known limitations of recall bias [67], minimized in this study
by interviewer administration. Even though this bias was
minimized by administration by trained interviewers, it may be
a factor contributing to the difference in the findings here
compared to results found using prospective data such as EPIC [6]
and ATBC [5]. Once we removed the missing data, and stratified,
the sample sizes are small. Yet using the Bayesian approach, we
were able to control the false discovery rate to be less than 15%,
which for the number of findings of the study, comes to one
expected false positive per model. Even though the false discovery
rate was controlled, and recall bias was minimized, an important
next step is to externally validate these findings with independent,
prospectively collected data sets.
We would also like to discuss our independence assumptions.
When constructing our priors, we modeled genetic covariance
using linkage disequilibrium, but assumed nutrition variables and
gene-nutrition interactions to be independent. Prior definitions are
not rigid assumptions, but rather reflection of the prior belief of the
modeler [68]. Previous simulation studies involving LD as a prior
showed that it can reduce false positives from multicollinearity in
the presence of high LD [20,69,70]. This covariance argument can
generalize to correlation between any covariates. As a secondary
precaution we computed the false discovery rate as described in
[49], and it was controlled at around 15%.
To our knowledge, this is one of the first studies to jointly assess
the association between lung cancer and a comprehensive panel of
candidate genes in the folate pathway and nutrients related to
folate metabolism, and nutrient-gene interactions. Furthermore,
we used a novel Bayesian model averaging method to explore
these associations. Strengths of this study include a sample size
large enough to stratify by smoking status and jointly investigate
multiple factors. Jointly modeling gene and nutrient factors
allowed us to comprehensively assess the impact of folate
metabolism and lung cancer risk. Through our stratified models,
we also show that the genetic and nutritional impact on lung
cancer risk differs by smoking status. These preliminary findings
suggest that the impact of dietary interventions for lung cancer risk
may be modified by genotypes in key folate metabolism genes.
These findings mark a first step toward more personalized
interventions to reduce cancer risk. In developing dietary
interventions to reduce lung cancer risk, we not only need to
consider smoking status, but also potentially, the genotypes of
folate metabolism genes, and how they interact with the nutrient
intake levels.
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